In this webinar, presenters discuss the data on COVID-19 vaccines in immunocompromised people, the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and Centers for Disease Control and Prevention's (CDC) guidance on additional COVID-19 doses in immunocompromised people.
This website includes information for COVID-19 vaccination administration, storage and handing, reporting, and patient education for each specific vaccine.
This page provides information about the Centers for Disease Control & Prevention (CDC) COVID-19 Vaccination Program ─ with vaccine being provided by the federal government ─ to ensure all people in the United States who wish to be vaccinated can receive vaccine without barriers, to the greatest extent possible. This page also serves as repository for any updates to the Centers for Disease Control & Prevention (CDC) COVID-19 Vaccination Provider Agreement including recommendations, requirements, and other useful information for vaccination providers participating in the program.
This webpage provides updated information from the CDC on a range of COVID-19 clinical care topics.
The Centers for Disease Control and Prevention (CDC) provides answers to a variety of frequently asked questions related to COVID-19 vaccine booster shots.
The COVID-19 County Check Tool provides a snapshot of county levels of community transmission over the past 7 days. The tool also displays guidance on masking based on how the virus is spreading.
This webpage provides information on COVID-19 vaccination administration, storage and handling, reporting, and patient education for each specific vaccine.
This toolkit contains ready-made materials you can use to inform your healthcare teams and other staff about the COVID-19 vaccine.
This page outlines the data systems that have been integrated to ensure successful tracking and reporting of COVID-19 vaccine distribution and administration data. Each section includes an overview and information on trainings to support implementation.
This document contains a list of immunization training and educational materials, including basic and COVID-19-vaccine-specific information.
This Centers for Disease Control and Prevention (CDC) webpage offers the latest information about COVID-19 vaccination recommendations and access in long-term care settings.
To help share clear consistent, and credible information about COVID-19 vaccines, nursing home leadership can use this toolkit for communicating with staff.
This module provides healthcare providers with information about COVID-19 vaccine Emergency Use Authorization and safety, as well as general information about vaccine storage, handling, administration, and reporting.
This webpage explains why COVID-19 vaccines are safe and effective and provides links to data on vaccine effectiveness and vaccine breakthrough infections.
This webpage discusses the value of vaccination in the long-term care setting for residents and staff.
This webpage provides information on the vaccines that are approved and authorized in the United States to prevent COVID-19.
This report examines the effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infection among nursing home residents.
This webpage provides information on the safety and effectiveness of the COVID-19 vaccines.
This webpage provides answers to some commonly asked questions regarding COVID-19 vaccination.
This flyer provides instructions on how to use V-safe, a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination.
On this webpage, the Centers for Disease Control and Prevention (CDC) explains how jurisdictions can ensure vaccine access for staff and residents in long-term care settings.
On this webpage, CDC provides Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States.
These interim considerations provide information on preparing for the initial assessment and management of anaphylaxis following COVID-19 vaccination.
This guidance for infection prevention and control for healthcare personnel during COVID-19 applies to all U.S. settings where healthcare is delivered, including home health. The Centers for Disease Control and Prevention (CDC) has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.
Find information and resources from the Centers for Disease Control and Prevention (CDC) to help long-term care providers when coordinating access to COVID-19 vaccines on-site or in the local community.